The Cigna Group (NYSE: CI), a healthcare firm centered on medical insurance coverage and associated companies, Thursday reported a pointy enhance in revenues for the primary quarter of 2024.
First-quarter revenues climbed 23% yearly to $57.3 billion, primarily reflecting a 31% income progress within the core Pharmacy phase. For fiscal 2024, the administration expects revenues to be roughly $235 billion, on an adjusted foundation.
Adjusted working revenue, on a per-share foundation, rose 20% year-over-year to $6.47 in Q1. For the complete fiscal 12 months, Cigna is in search of an adjusted working revenue of round $8.07 billion.
In the meantime, the corporate reported a shareholders’ web lack of $277 million or $0.97 per share for the March quarter, in comparison with a revenue of $1.27 billion or $4.24 per share within the year-ago quarter.
